Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02582359
Title MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

acute myeloid leukemia

Therapies

Cytarabine + Daunorubicin + Ixazomib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.